CoreCap Advisors LLC Sells 2,689 Shares of CME Group Inc. $CME

CoreCap Advisors LLC lowered its stake in CME Group Inc. (NASDAQ:CME) by 44.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,364 shares of the financial services provider’s stock after selling 2,689 shares during the period. CoreCap Advisors LLC’s holdings in CME Group were worth $909,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in CME. Jessup Wealth Management Inc lifted its holdings in CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after purchasing an additional 36 shares during the last quarter. First Horizon Advisors Inc. lifted its stake in shares of CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after buying an additional 36 shares during the last quarter. Great Lakes Advisors LLC boosted its holdings in shares of CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock worth $441,000 after buying an additional 37 shares during the period. MBM Wealth Consultants LLC grew its stake in CME Group by 2.7% in the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after buying an additional 37 shares during the last quarter. Finally, Beaumont Financial Advisors LLC grew its stake in CME Group by 2.0% in the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after buying an additional 38 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard bought 251 shares of the firm’s stock in a transaction dated Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the transaction, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Royal Bank Of Canada boosted their target price on shares of CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a research report on Friday, December 5th. Piper Sandler increased their target price on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. The Goldman Sachs Group lowered their target price on CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a report on Thursday, December 4th. Barclays upped their price target on CME Group from $280.00 to $304.00 and gave the stock an “equal weight” rating in a report on Friday, December 12th. Finally, UBS Group restated a “neutral” rating on shares of CME Group in a research note on Tuesday. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $291.06.

CME Group Trading Down 1.6%

CME Group stock opened at $262.45 on Friday. The business has a 50 day moving average price of $273.95 and a two-hundred day moving average price of $271.89. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $225.46 and a 12 month high of $290.79. The stock has a market cap of $94.64 billion, a price-to-earnings ratio of 25.43, a price-to-earnings-growth ratio of 3.44 and a beta of 0.27.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.CME Group’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.68 earnings per share. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were paid a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is currently 48.45%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.